1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,515 | 0,530 | 10:32 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Stagezero Life Sciences Ltd (2): Stagezero to distribute COVID-19 test kits in Canada | - | Stockwatch | ||
| Mi | StageZero Life Sciences Ltd: StageZero Life Sciences to Offer COVID-19 Saliva Test Kits Throughout Canada | 184 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / May 5, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS) ("StageZero" or the "Company"), a specialist in PCR testing dedicated to the early detection of multiple diseases through... ► Artikel lesen | |
| 19.04. | StageZero Life Sciences to Present at the Planet MicroCap Showcase: VIRTUAL on Thursday April 22, 2021 | 227 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / April 19, 2021 / StageZero Life Sciences (TSX:SZLS), a company dedicated to early detection of multiple disease states through whole blood, today announced that it will be... ► Artikel lesen | |
| STAGEZERO LIFE SCIENCES Aktie jetzt für 0€ handeln | |||||
| 07.04. | StageZero Life Sciences has price target cut at Clarus | 7 | Cantech Letter | ||
| 05.04. | Stagezero Life Sciences Ltd (2): Stagezero advertises Aristotle cancer test | 3 | Stockwatch | ||
| 05.04. | StageZero Life Sciences Ltd: StageZero Life Sciences Introduces Aristotle, The First Multi-Cancer Test From A Single Sample of Blood | 245 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / April 5, 2021 / StageZero Life Sciences, Ltd (TSX:SZLS) ("StageZero" or the "Company") on Thursday April 1st, announced it was partnering with Health Clinics and Care Oncology... ► Artikel lesen | |
| 02.04. | Stagezero Life Sciences Ltd (2): Stagezero loses $6.86-million in 2020 | 2 | Stockwatch | ||
| 01.04. | Stagezero Life Sciences reports Q4 results | 5 | Seeking Alpha | ||
| 01.04. | StageZero Life Sciences Ltd: StageZero Life Sciences Announces Q4 2020 and Year End Financial Results and Operational Update | 431 | ACCESSWIRE | Q4 Revenue of $2.82 Million
TORONTO, ON / ACCESSWIRE / April 1, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS) ("StageZero" or the "Company") reports financial results for the three and twelve months... ► Artikel lesen | |
| 01.04. | Stagezero Life Sciences Ltd (2): Stagezero Life Sciences to resume at 6:36 a.m. PT | 4 | Stockwatch | ||
| 01.04. | Stagezero Life Sciences Ltd (2): Stagezero signs LOI to acquire Health Clinics | 4 | Stockwatch | ||
| 01.04. | Stagezero Life Sciences Ltd (2): Stagezero Life Sciences halted at 6:31 a.m. PT | 1 | Stockwatch | ||
| 01.04. | StageZero Life Sciences Ltd: StageZero Life Sciences Announces Signed Letter of Intent for the Acquisition of Health Clinics Limited | 321 | ACCESSWIRE | Initiates AVRT program for the early detection of diseases, with a focus on cancer incorporating its Aristotle multi-cancer panel
TORONTO, ON / ACCESSWIRE / April 1, 2021 / StageZero Life Sciences... ► Artikel lesen | |
| 31.03. | Stagezero Life Sciences Ltd (2): Stagezero to release 2020 financial results today | 4 | Stockwatch | ||
| 31.03. | StageZero Life Sciences Ltd: StageZero Announces 2020 Year End Analyst and Investor Call | 368 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / March 31, 2021 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS) today announced that it will release its Fourth Quarter 2020 and Year End operational results... ► Artikel lesen | |
| 31.12.20 | Stagezero Life Sciences Ltd (2): Stagezero hires McGovern as auditor, BDO resigns | 9 | Stockwatch | ||
| 31.12.20 | StageZero Life Sciences Ltd: StageZero Life Sciences, Ltd Announces Appointment of New Auditors | 565 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / December 31, 2020 / StageZero Life Sciences, Ltd. (TSX:SZLS) ("StageZero" or the "Company") announced today that it has engaged Toronto based McGovern Hurley LLP as its auditors.... ► Artikel lesen | |
| 07.12.20 | StageZero Life Sciences Ltd: StageZero Announces Third Quarter Analyst and Investor Call | 291 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / December 7, 2020 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS) today announced StageZero's Chairman and CEO, James R Howard-Tripp, will host a conference... ► Artikel lesen | |
| 04.12.20 | Stagezero Life Sciences Ltd (2): Stagezero closes $7.21-million offering | 5 | Stockwatch | ||
| 04.12.20 | StageZero Life Sciences Ltd. Announces Closing of Public Offering for Proceeds of $7.2 million | 431 | ACCESSWIRE | NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES
TORONTO, ON / ACCESSWIRE / December 4, 2020 / StageZero Life Sciences Ltd. (TSX:SZLS) (the "Company")... ► Artikel lesen |
Seite:
1 2 3 Weiter >>
59 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 147,60 | -0,84 % | Carl Zeiss Meditec (AFX) - Folgt auf die starken Quartalszahlen jetzt der Breakout? >>> BREAKOUT-SETUP <<< | Breakout Trading-Strategie
Symbol: AFX ISIN: DE0005313704
Rückblick: Die Carl Zeiss Meditec AG ist einer der weltweit führenden Medizintechnik-Anbieter. Carl Zeiss bietet Lösungen im Bereich... ► Artikel lesen | |
| INTUITIVE SURGICAL | 700,40 | +0,29 % | 10 Worte des CEOs von Intuitive Surgical, die Milliarden für Investoren bedeuten könnten | Krankenhäuser, die von COVID-19-Ausbrüchen überrollt wurden, mussten in den letzten anderthalb Jahren eine Menge Operationen verschieben. Das war nicht gut für Unternehmen, die sich auf ein steigendes... ► Artikel lesen | |
| RELAY MEDICAL | 0,206 | -2,83 % | Relay Medical: Umsätze und Großaufträge pflastern den Weg zum Erfolg! | ||
| PLUS THERAPEUTICS | 1,954 | -1,51 % | Plus Therapeutics shares rise 5% on Rhenium NanoLiposome development contract | ||
| EVOFEM BIOSCIENCES | 1,101 | -2,39 % | GSK ViiV's Dovato squares off against Evofem's Phexxi in final FierceMadness DTC ad matchup | ||
| ATOSSA THERAPEUTICS | 2,000 | -0,50 % | Avance Clinical Client Atossa Therapeutics Announces Final Results from Phase 1 Clinical Study Showing Safety and Tolerability of AT-301 Nasal Spray Being Developed for COVID-19 | ADELAIDE, AU, Mar 12, 2021 - (ACN Newswire) - The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical congratulated Atossa Therapeutics... ► Artikel lesen | |
| SPINEWAY | 0,002 | +6,67 % | SPINEWAY: Registration of 2020 document with the French financial markets authority | ||
| MOUNTAIN VALLEY MD | 0,643 | -2,58 % | Mountain Valley MD files patent and begins pre-clinical trials to enter USD $100 billion cancer drug market | VANCOUVER, BC, May 4, 2021 /PRNewswire/ - Mountain Valley MD (CSE: MVMD) (FRA: 20MP) (OTCQB: MVMDF) announced it has filed a novel cancer adjuvant patent related to breast cancer, metastatic melanoma... ► Artikel lesen | |
| ASENSUS SURGICAL | 1,703 | +1,18 % | Asensus Surgical Is a Great Investment, but Not Much of a Retail Trade | ||
| EMPOWER CLINICS | 0,331 | -8,07 % | Empower Clinics Inc.: Empower Clinics Hits Critical Milestone for KAI Laboratory Expansion, Celebrates Continued Patient Growth | KAI LAB now weeks away from its grand opening
VANCOUVER, BC / ACCESSWIRE / May 4, 2021 / EMPOWER CLINICS INC. (CBDT: CSE) (8EC: Frankfurt) (EPWCF: OTCQB) ("Empower" or the "Company") an integrated... ► Artikel lesen | |
| MEDIVOLVE | 0,118 | +8,29 % | Medivolve Inc: Medivolve investment clears first stage of testing | ||
| REWALK ROBOTICS | 1,416 | -0,28 % | ReWalk Robotics: Riding The Frenzy | ||
| VOLITIONRX | - | - | VolitionRx Limited Announces Participation in the Benzinga Biotech Small Cap Conference | Detroit, Michigan--(Newsfile Corp. - March 19, 2021) - VolitionRx Limited (NYSE: VNRX) will be presenting at the Benzinga Biotech Small Cap Conference taking place on March 24-25, 2021. We invite our... ► Artikel lesen | |
| CELSION | 0,925 | +3,35 % | Celsion CORP: Celsion Management Participates in Alliance Global Partners Virtual Series | ||
| EKSO BIONICS | 4,500 | -1,06 % | Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q1 2021 Results - Earnings Call Transcript |
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
